A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD) | Frenkel-Pinter Lab

A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD)

Citation:

Ronit Shaltiel-Karyo, Frenkel-Pinter, Moran , Rockenstein, Edward , Patrick, Christina , Levy-Sakin, Michal , Schiller, Abigail , Egoz-Matia, Nirit , Masliah, Eliezer , Segal, Daniel , and Gazit, Ehud . 2013. “A Blood-Brain Barrier (Bbb) Disrupter Is Also A Potent Α-Synuclein (Α-Syn) Aggregation Inhibitor: A Novel Dual Mechanism Of Mannitol For The Treatment Of Parkinson Disease (Pd)”. Journal Of Biological Chemistry, 288, 24, Pp. 17579-17588.